Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VEDOLIZUMAB for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 13 adverse event reports in the FDA FAERS database where VEDOLIZUMAB was used for Psoriasis.

Most Reported Side Effects for VEDOLIZUMAB

Side Effect Reports % Deaths Hosp.
Off label use 21,017 28.5% 637 5,998
Colitis ulcerative 13,455 18.2% 155 3,107
Crohn's disease 9,759 13.2% 227 3,122
Drug ineffective 8,424 11.4% 180 2,439
Diarrhoea 7,493 10.2% 399 2,536
Abdominal pain 6,401 8.7% 117 2,324
Fatigue 5,477 7.4% 394 1,730
Haematochezia 5,215 7.1% 8 1,046
Frequent bowel movements 4,527 6.1% 103 1,188
Arthralgia 4,028 5.5% 308 1,164
Malaise 3,684 5.0% 262 1,565
Nausea 3,582 4.9% 304 1,456
Headache 3,574 4.8% 355 1,237
Inappropriate schedule of product administration 3,259 4.4% 70 828
Product dose omission issue 3,078 4.2% 47 859

Other Indications for VEDOLIZUMAB

Colitis ulcerative (33,987) Crohn's disease (28,718) Product used for unknown indication (8,955) Inflammatory bowel disease (1,342) Colitis (805) Colitis microscopic (286) Proctitis ulcerative (146) Deep vein thrombosis (139) Immune-mediated enterocolitis (89) Pouchitis (86)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

VEDOLIZUMAB Full Profile All Psoriasis Drugs VEDOLIZUMAB Demographics VEDOLIZUMAB Timeline